Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)
NASDAQ·Financial Services·Shell Companies
$10.62
+0.09%
Mkt Cap $357.74M
No analyst coverage available
We don't have analyst ratings or price target data for Drugs Made In America Acquisition Corp. Ordinary Shares yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.